Rise Advisors’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-471
Closed -$27.7K 770
2025
Q3
$27.7K Buy
471
+1
+0.2% +$57 0.01% 411
2025
Q2
$26.5K Buy
470
+2
+0.4% +$113 0.01% 394
2025
Q1
$28.5K Buy
468
+1
+0.2% +$61 0.01% 338
2024
Q4
$27.2K Buy
467
+1
+0.2% +$62 0.01% 444
2024
Q3
$30.3K Buy
466
+2
+0.4% +$128 0.01% 411
2024
Q2
$28.4K Buy
464
+1
+0.2% +$60 0.02% 406
2024
Q1
$28.7K Buy
463
+3
+0.7% +$180 0.02% 403
2023
Q4
$26.4K Sell
460
-195
-30% -$10.6K 0.02% 224
2023
Q3
$35.5K Sell
655
-780
-54% -$43.6K 0.03% 170
2023
Q2
$80.5K Hold
1,435
0.06% 117
2023
Q1
$78.3K Sell
1,435
-995
-41% -$54.6K 0.06% 124
2022
Q4
$138K Buy
2,430
+5
+0.2% +$276 0.11% 79
2022
Q3
$123K Buy
2,425
+10
+0.4% +$540 0.1% 81
2022
Q2
$130K Buy
2,415
+10
+0.4% +$549 0.13% 76
2022
Q1
$139K Buy
2,405
+255
+12% +$14.2K 0.13% 79
2021
Q4
$129K Buy
+2,150
New +$123K 0.12% 84

Other funds holding IYH

Rise Advisors's IYH Position: Q4 2025 in Review

Rise Advisors sold out of iShares US Healthcare ETF (IYH) in Q4 2025, closing a stake of 471 shares — an estimated $27.7K sold.

Rise Advisors first reported a position in IYH in Q4 2021 and held it in 16 quarters. The position peaked at $139K in Q1 2022. 545 funds tracked by Wall St. Rank hold IYH as of Q4 2025.

  • Rise Advisors reported no remaining iShares US Healthcare ETF position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 471 iShares US Healthcare ETF shares in Q4 2025, an estimated $27.7K.
  • Rise Advisors first reported a position in iShares US Healthcare ETF in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's iShares US Healthcare ETF position peaked at $139K in Q1 2022.
  • 545 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.